Current Challenges of R/R MM Management and Innovation Updates

 

A

Treatment Approach in Patients With R/R MM Who Have Failed at Least 4 Lines of Therapies

By Abdullah Khan
99 views
April 3, 2023
0 Comments
Login to view comments. Click here to Login
Current Challenges of R/R MM Management and Innovation Updates
07:05
ASH 2022 Conference Coverage

ASH 2022 Phase 1/2 Results From MonumenTAL-1: Talquetamab, a G Prote…

Feat. A. Chari
25:36
MyCancerHaven

Experts Discuss the Bispecific Antibody Talquetamab in Patients With…

Feat. R. Vij, G. Kaur
17:42
Abdullah Khan

Treatment Approach in Patients With R/R MM Who Have Failed at Least …

41:23
Cleveland Clinic Taussig Cancer Institute

Understanding Resistance in R/R MM: Mechanisms, Current Practice, an…

Feat. F. Anwer
20:11
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Combination Therapy Trials in Myeloma - A …

Feat. A. Jakubowiak
03:33
ecancer

ASCO® 2023 Insights: "TRIMM-2 Study Summary - Update on Talquet…

Feat. B. Dholaria
05:20
ecancer

ASCO® 2023 Insights: "RedirecTT-1 Study Summary - Teclistamab +…

Feat. Y. C. Cohen
52:39
Yale Cancer Center

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Feat. A. Chari
09:10
University of Colorado Division of Hematology

2023 Denver ASH Review: Updates in Multiple Myeloma (Updates in the …

Feat. D. Sherbenou
32:03
Indy Hematology Review

Emerging and Current Treatment of MM: What Should We Know and What S…

Feat. K. Anderson
54:12
Dana-Farber Cancer Institute

Symptom Management in Multiple Myeloma

Feat. S. Midha
44:49
Dana-Farber Cancer Institute

Recent Updates in Multiple Myeloma

Feat. K. Anderson
27:10
Yale Cancer Center

Highlights in R/R Myeloma and AL Amyloidosis From ASH 2022

Feat. S. Browning
19:18
Total Health

Updates to Management of Patients With Multiple Myeloma

Feat. S. Kumar
41:46
Yale Cancer Center

Early Detection and Interception in Myeloma: The PROMISE Study

Feat. I. Ghobrial
17:32
Current Challenges in Hematology

Patient Journey for a Transplant-Ineligible Patient With MM From 1L …

Feat. R. Mina
15:32
ASH 2022 Conference Coverage

Novel Approaches to Myeloma Burden Assessment

Feat. T. Kourelis
06:16
ASH 2022 Conference Coverage

U.S. Myeloma CAR-T Consortium Real World Experience: Factors Associa…

Feat. H. Hashmi
14:16
ASH 2022 Conference Coverage

Assessing Disease Risk in Multiple Myeloma: High or Low?

Feat. T. Schmidt
12:43
Oliver Van Oekelen

Outcomes of MM Pts Progressing After BCMA-Targeted CAR T-Cell Therapy